CNC - Center for Neuroscience and Cell Biology, CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, UC-Biotech, Biocant Park, Cantanhede, Portugal.
Ph.D. Programme in Experimental Biology and Biomedicine (PDBEB), Institute for Interdisciplinary Research (IIIUC), University of Coimbra, Coimbra, Portugal.
Clin Sci (Lond). 2023 Sep 13;137(17):1347-1372. doi: 10.1042/CS20230048.
Maternal obesity (MO) is rising worldwide, affecting half of all gestations, constituting a possible risk-factor for some pregnancy-associated liver diseases (PALD) and hepatic diseases. PALD occur in approximately 3% of pregnancies and are characterized by maternal hepatic oxidative stress (OS) and mitochondrial dysfunction. Maternal hepatic disease increases maternal and fetal morbidity and mortality. Understanding the role of MO on liver function and pathophysiology could be crucial for better understanding the altered pathways leading to PALD and liver disease, possibly paving the way to prevention and adequate management of disease. We investigated specific hepatic metabolic alterations in mitochondria and oxidative stress during MO at late-gestation. Maternal hepatic tissue was collected at 90% gestation in Control and MO ewes (fed 150% of recommended nutrition starting 60 days before conception). Maternal hepatic redox state, mitochondrial respiratory chain (MRC), and OS markers were investigated. MO decreased MRC complex-II activity and its subunits SDHA and SDHB protein expression, increased complex-I and complex-IV activities despite reduced complex-IV subunit mtCO1 protein expression, and increased ATP synthase ATP5A subunit. Hepatic MO-metabolic remodeling was characterized by decreased adenine nucleotide translocator 1 and 2 (ANT-1/2) and voltage-dependent anion channel (VDAC) protein expression and protein kinase A (PKA) activity (P<0.01), and augmented NAD+/NADH ratio due to reduced NADH levels (P<0.01). MO showed an altered redox state with increased OS, increased lipid peroxidation (P<0.01), decreased GSH/GSSG ratio (P=0.005), increased superoxide dismutase (P=0.03) and decreased catalase (P=0.03) antioxidant enzymatic activities, lower catalase, glutathione peroxidase (GPX)-4 and glutathione reductase protein expression (P<0.05), and increased GPX-1 abundance (P=0.03). MO-related hepatic changes were more evident in the right lobe, corroborated by the integrative data analysis. Hepatic tissue from obese pregnant ewes showed alterations in the redox state, consistent with OS and MRC and metabolism remodeling. These are hallmarks of PALD and hepatic disease, supporting MO as a risk-factor and highlighting OS and mitochondrial dysfunction as mechanisms responsible for liver disease predisposition.
母体肥胖(MO)在全球范围内呈上升趋势,影响了半数妊娠,可能成为一些与妊娠相关的肝病(PALD)和肝疾病的危险因素。PALD 约占妊娠的 3%,其特征是母体肝氧化应激(OS)和线粒体功能障碍。母体肝疾病增加了母体和胎儿的发病率和死亡率。了解 MO 对肝功能和病理生理学的作用可能对更好地理解导致 PALD 和肝病的改变途径至关重要,这可能为疾病的预防和适当管理铺平道路。我们研究了晚期 MO 时线粒体和氧化应激的特定肝代谢改变。在对照和 MO 母羊(在受孕前 60 天开始摄入推荐营养的 150%)的妊娠 90%时收集母肝组织。研究了母体肝的氧化还原状态、线粒体呼吸链(MRC)和 OS 标志物。MO 降低了 MRC 复合物-II 的活性及其亚单位 SDHA 和 SDHB 的蛋白表达,尽管复合物-IV 的亚单位 mtCO1 蛋白表达降低,但复合物-I 和复合物-IV 的活性增加,并且增加了 ATP 合酶 ATP5A 亚单位。MO 导致肝代谢重塑的特征是减少腺嘌呤核苷酸转运蛋白 1 和 2(ANT-1/2)和电压依赖性阴离子通道(VDAC)蛋白表达和蛋白激酶 A(PKA)活性(P<0.01),并由于 NADH 水平降低而增加 NAD+/NADH 比(P<0.01)。MO 显示出改变的氧化还原状态,伴有 OS 增加、脂质过氧化增加(P<0.01)、GSH/GSSG 比值降低(P=0.005)、超氧化物歧化酶增加(P=0.03)和过氧化氢酶降低(P=0.03)抗氧化酶活性,CAT、谷胱甘肽过氧化物酶(GPX)-4 和谷胱甘肽还原酶蛋白表达降低(P<0.05),GPX-1 丰度增加(P=0.03)。在右叶中观察到与 MO 相关的肝变化更为明显,这与综合数据分析结果一致。肥胖孕妇的肝组织显示氧化还原状态改变,与 OS、MRC 和代谢重塑一致。这些都是 PALD 和肝病的特征,支持 MO 作为危险因素,并强调 OS 和线粒体功能障碍是导致肝病易感性的机制。